FOXD4L5

gene
On this page

Also known as bA15J10.2OTTHUMG00000013332

Summary

FOXD4L5 (forkhead box D4 like 5, HGNC:18522) is a protein-coding gene on chromosome 9q21.11, encoding Forkhead box protein D4-like 5 (Q5VV16).

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in anatomical structure morphogenesis; cell differentiation; and regulation of transcription by RNA polymerase II. Predicted to be located in chromatin.

Source: NCBI Gene 653427 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 165 total
  • MANE Select transcript: NM_001126334

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18522
Approved symbolFOXD4L5
Nameforkhead box D4 like 5
Location9q21.11
Locus typegene with protein product
StatusApproved
AliasesbA15J10.2, OTTHUMG00000013332
Ensembl geneENSG00000204779
Ensembl biotypeprotein_coding
Entrez653427

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000377420

RefSeq mRNA: 1 — MANE Select: NM_001126334 NM_001126334

CCDS: CCDS47977

Canonical transcript exons

ENST00000377420 — 1 exons

ExonStartEnd
ENSE000016817696528210165285209

Expression profiles

Bgee: expression breadth broad, 72 present calls, max score 82.70.

Top tissues by expression

90 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047382.70gold quality
cortical plateUBERON:000534361.79gold quality
right uterine tubeUBERON:000130258.63gold quality
cerebellar hemisphereUBERON:000224554.68gold quality
cerebellumUBERON:000203754.66gold quality
cerebellar cortexUBERON:000212954.63gold quality
superior frontal gyrusUBERON:000266154.54gold quality
right hemisphere of cerebellumUBERON:001489053.20gold quality
stromal cell of endometriumCL:000225550.99silver quality
granulocyteCL:000009450.94silver quality
Ammon’s hornUBERON:000195450.91gold quality
Brodmann (1909) area 9UBERON:001354050.60gold quality
prefrontal cortexUBERON:000045150.37gold quality
cerebral cortexUBERON:000095649.99gold quality
frontal cortexUBERON:000187049.99gold quality
nucleus accumbensUBERON:000188249.97gold quality
dorsolateral prefrontal cortexUBERON:000983449.88gold quality
anterior cingulate cortexUBERON:000983549.43gold quality
lower esophagus mucosaUBERON:003583449.28gold quality
right frontal lobeUBERON:000281049.16gold quality
putamenUBERON:000187448.63gold quality
ganglionic eminenceUBERON:000402348.61silver quality
brainUBERON:000095548.57gold quality
caudate nucleusUBERON:000187348.39gold quality
primary visual cortexUBERON:000243647.96gold quality
hypothalamusUBERON:000189846.47gold quality
tonsilUBERON:000237246.24gold quality
endometriumUBERON:000129546.23silver quality
colonic epitheliumUBERON:000039745.59gold quality
amygdalaUBERON:000187644.14gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.65

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

42 targeting FOXD4L5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3924100.0072.092394
HSA-MIR-480399.9871.993117
HSA-MIR-426799.9666.532368
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-6499-3P99.9066.381212
HSA-MIR-95-5P99.8972.173973
HSA-MIR-6739-5P99.8067.872806
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-6733-5P99.7467.942759
HSA-MIR-7154-5P99.6970.521900
HSA-MIR-3679-3P99.6469.881599
HSA-MIR-6716-5P99.5668.621244
HSA-MIR-315399.5567.592337
HSA-MIR-4761-5P99.5166.69804
HSA-MIR-653-5P99.4667.351300
HSA-MIR-130A-5P99.3370.262623
HSA-MIR-1211399.3267.541072
HSA-MIR-751599.3168.221795
HSA-MIR-120699.3069.321016
HSA-MIR-312599.1468.492269
HSA-MIR-146A-3P99.1368.991881
HSA-MIR-3152-3P99.1066.35678
HSA-MIR-6749-3P99.0065.731443
HSA-MIR-391698.9968.042155
HSA-MIR-6859-5P98.9968.072049
HSA-MIR-4738-3P98.9867.981846
HSA-MIR-453998.7867.18888
HSA-MIR-876-3P98.7668.23945
HSA-MIR-219A-2-3P98.6268.78797
HSA-MIR-31-5P98.5868.351239

Cross-species orthologs

1 orthologs

OrganismSymbolGene ID
mus_musculusFoxd4ENSMUSG00000051490

Paralogs (41): FOXP3 (ENSG00000049768), FOXC1 (ENSG00000054598), FOXJ2 (ENSG00000065970), FOXF1 (ENSG00000103241), FOXN1 (ENSG00000109101), FOXM1 (ENSG00000111206), FOXP1 (ENSG00000114861), FOXO3 (ENSG00000118689), FOXA2 (ENSG00000125798), FOXA1 (ENSG00000129514), FOXJ1 (ENSG00000129654), FOXK2 (ENSG00000141568), FOXO1 (ENSG00000150907), FOXH1 (ENSG00000160973), FOXQ1 (ENSG00000164379), FOXK1 (ENSG00000164916), FOXD4 (ENSG00000170122), FOXA3 (ENSG00000170608), FOXB1 (ENSG00000171956), FOXR1 (ENSG00000176302), FOXL1 (ENSG00000176678), FOXC2 (ENSG00000176692), FOXE1 (ENSG00000178919), FOXS1 (ENSG00000179772), FOXL2 (ENSG00000183770), FOXO4 (ENSG00000184481), FOXD4L1 (ENSG00000184492), FOXD4L4 (ENSG00000184659), FOXD2 (ENSG00000186564), FOXI2 (ENSG00000186766), FOXE3 (ENSG00000186790), FOXD3 (ENSG00000187140), FOXD4L3 (ENSG00000187559), FOXR2 (ENSG00000189299), FOXJ3 (ENSG00000198815), FOXO6 (ENSG00000204060), FOXB2 (ENSG00000204612), FOXI3 (ENSG00000214336), FOXL3 (ENSG00000248767), FOXD1 (ENSG00000251493)

Protein

Protein identifiers

Forkhead box protein D4-like 5Q5VV16 (reviewed: Q5VV16)

All UniProt accessions (1): Q5VV16

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Nucleus.

RefSeq proteins (1): NP_001119806* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001766Fork_head_domDomain
IPR018122TF_fork_head_CS_1Conserved_site
IPR030456TF_fork_head_CS_2Conserved_site
IPR036388WH-like_DNA-bd_sfHomologous_superfamily
IPR036390WH_DNA-bd_sfHomologous_superfamily
IPR050211FOX_domain-containingFamily

Pfam: PF00250

UniProt features (6 total): region of interest 2, compositionally biased region 2, chain 1, DNA-binding region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5VV16-F157.030.17

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 20 (showing top): chr9q21, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR95_5P, MIR4753_3P, MIR130A_5P, MIR7154_5P, MIR6818_3P, MIR31_5P, MIR1206, MIR877_5P, MIR3152_3P, MIR4761_5P, MIR1266_3P, MANNO_MIDBRAIN_NEUROTYPES_HGABA

GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), anatomical structure morphogenesis (GO:0009653), cell differentiation (GO:0030154), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), sequence-specific DNA binding (GO:0043565)

GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription2
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
transcription by RNA polymerase II1
developmental process1
anatomical structure development1
cellular developmental process1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
nucleic acid binding1
transcription cis-regulatory region binding1
transcription regulator activity1
DNA binding1
chromosome1
cellular anatomical structure1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

468 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
FOXD4L5ANKRD20A2PQ5SQ80652
FOXD4L5ZNF595Q8IYB9508
FOXD4L5POU5F2Q8N7G0390
FOXD4L5MYO18BQ8IUG5378
FOXD4L5ARHGEF5Q12774375
FOXD4L5NKX1-1Q15270375
FOXD4L5NKX1-2Q9UD57339
FOXD4L5MUC12Q9UKN1328
FOXD4L5NKX2-4Q9H2Z4322
FOXD4L5NKX2-6A6NCS4320
FOXD4L5NKX6-3A6NJ46290
FOXD4L5FOXR2Q6PJQ5277
FOXD4L5NKX2-8O15522267
FOXD4L5POU6F2P78424265
FOXD4L5SOX14O95416263
FOXD4L5POU6F1Q14863263

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A0A0U1RRK4, A0A1W2PPE3, A0A1W2PR82, A0A2R8Y2Y2, A0A494C0N9, A0A494C0Y3, A0JNN8, A6NF83, A6NHQ4, A6QPM6, A8E4L3, A8MTW9, B2KGE5, C9JVW0, I3L1E1, O43541, O75474, O75638, P0C7X2, P70339, P89439, Q02080, Q05215, Q12950, Q3SYB3, Q5T230, Q5VV16, Q6NZ36, Q6NZY7, Q6P1X6, Q6VB84, Q6VUC0, Q6VUP9, Q6ZSJ8, Q7RTU5, Q7TNS8, Q80WY3, Q86SI9, Q86UU5, Q8K025

Diamond homologs: A0A078BQN7, A0A1W2PRP0, A0A8V0YY16, A1L1S5, A3KNJ3, A8MTJ6, A8XJN7, B5RHS5, D3Z120, F1R8Z9, O00358, O17617, O43638, O54743, O60129, O88470, P32027, P32028, P32030, P32315, P42128, P55316, P56260, P58012, P79772, P85037, P91278, Q00939, Q01167, Q02360, Q12946, Q12947, Q12948, Q12950, Q12951, Q12952, Q13461, Q19802, Q1A1A1, Q1A1A2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

165 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance159
Likely benign6
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

45 predictions. Top by Δscore:

VariantEffectΔscore
9:65284460:ATGTT:Aacceptor_gain0.5300
9:65284463:CAACA:Cacceptor_gain0.5100
9:65284481:C:Tacceptor_gain0.4600
9:65284461:TGTTG:Tacceptor_gain0.4500
9:65284462:GTTGC:Gacceptor_gain0.4500
9:65284462:A:AGacceptor_gain0.4400
9:65284479:TGC:Tacceptor_gain0.4200
9:65284463:T:TCacceptor_gain0.4000
9:65284464:GCAAC:Gacceptor_gain0.4000
9:65284465:TGCAA:Tacceptor_gain0.4000
9:65285142:A:Cdonor_gain0.3700
9:65284461:A:Gacceptor_gain0.3500
9:65285132:C:CAdonor_gain0.3500
9:65285140:T:Gdonor_gain0.3500
9:65284479:G:Aacceptor_gain0.3400
9:65285131:G:GTdonor_gain0.3400
9:65284463:T:Cacceptor_gain0.3300
9:65284453:GGGAT:Gacceptor_gain0.3000
9:65284454:GGATG:Gacceptor_gain0.3000
9:65284456:CATCC:Cacceptor_gain0.2900
9:65284457:TCATC:Tacceptor_gain0.2900
9:65284463:TTGC:Tacceptor_gain0.2900
9:65284815:C:Tacceptor_gain0.2900
9:65284813:G:Aacceptor_gain0.2800
9:65285018:C:Adonor_gain0.2800
9:65284462:AACA:Aacceptor_gain0.2700
9:65284455:G:Aacceptor_gain0.2600
9:65282246:C:CGacceptor_gain0.2500
9:65282291:T:TAacceptor_gain0.2400
9:65284455:ATCC:Aacceptor_gain0.2400

AlphaMissense

2674 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:65283832:C:AW182C1.000
9:65283832:C:GW182C1.000
9:65283880:G:CF166L1.000
9:65283880:G:TF166L1.000
9:65283881:A:CF166C1.000
9:65283882:A:GF166L1.000
9:65283787:A:CF197L0.999
9:65283787:A:TF197L0.999
9:65283789:A:GF197L0.999
9:65283802:G:CF192L0.999
9:65283802:G:TF192L0.999
9:65283803:A:CF192C0.999
9:65283804:A:GF192L0.999
9:65283834:A:GW182R0.999
9:65283834:A:TW182R0.999
9:65283881:A:GF166S0.999
9:65283890:T:AN163I0.999
9:65283906:G:CH158D0.999
9:65283911:A:TI156N0.999
9:65283922:C:AW152C0.999
9:65283922:C:GW152C0.999
9:65283924:A:GW152R0.999
9:65283924:A:TW152R0.999
9:65283952:G:CF142L0.999
9:65283952:G:TF142L0.999
9:65283954:A:GF142L0.999
9:65283967:G:CF137L0.999
9:65283967:G:TF137L0.999
9:65283969:A:GF137L0.999
9:65283803:A:GF192S0.998

dbSNP variants (sampled 300 via entrez): RS1000503011 (9:65286323 C>A,G), RS1001041499 (9:65285106 T>A), RS1001751773 (9:65283436 C>A,G), RS1002076765 (9:65282495 A>G), RS1007930470 (9:65284803 C>A,T), RS1009391852 (9:65286465 T>C), RS1017190138 (9:65282663 C>G,T), RS1017515371 (9:65283487 C>A,T), RS1018075710 (9:65283814 G>A), RS1018344940 (9:65284854 C>T), RS1024321638 (9:65282205 GT>G), RS1024753220 (9:65286498 C>T), RS1025293912 (9:65282805 C>A,T), RS1025870625 (9:65283557 G>A,C,T), RS1032062181 (9:65285150 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

4 total (human), top 4 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
Smokedecreases expression1
Urethanedecreases expression1
Okadaic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.